The poly (ADP-ribose) polymerase 1 (PARP-1) is a promising molecular target for the antitumor drug development. Overexpression or loss of PARP-1 leads to disturbances in the process of DNA repair and transcription of genes involved in DNA replication and cell cycle regulation and, as a consequence, to general genome instability. Increased PARP-1 activity is observed in numerous cancers [1, 2] , and considered as a possible mechanism of resistance to DNA-damaging therapeutics [3] . A high level of PARP-1 expression correlates with a more aggressive phenotype of cancers [4] . Many PARP-1 inhibitors are undergoing clinical trials, and four of them have been already approved for the treatment of cancer patients. These inhibitors are thought to exert their cytotoxicity through both inhibition of catalytic activity and trapping of DNA-PARP-1 complexes [5, 6] . Trapping of PARP-1 on DNA and formation of non-productive complexes was proved to be a more effective way to kill cancer cells than simple inhibition of PARP-1 activity. However, in the nuclei PARP-1 proteins interact with DNA organized into chromatin, and contribution of chromatin structure to PARP-1 trapping requires detailed investigation. Here we applied single-particle Förster resonance energy transfer (spFRET) microscopy (similar as described elsewhere [7-9]) to analyze PARP-1 trapping on nucleosomal templates by a new PARP-1 inhibitor 7-methylguanine (7-MG, Fig. 1 A) , which is able to accelerate apoptotic death of BRCA1-deficient breast cancer cells induced by cisplatin and doxorubicin [10] .
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Mononucleosomes are a convenient "minimal" experimental system mimicking the chromatin packing of DNA. To make mononucleosomes suitable for structural studies using spFRET microscopy, a pair of labels (donor, Cy3, and acceptor, Cy5) was introduced into neighboring gyres of nucleosomal DNA in positions +13/+91 bp relative to the beginning of nucleosomal DNA (Fig. 1 B) . Such labeling provides efficient FRET between the fluorophores without disturbance of histone-DNA contacts in the assembled nucleosomes [9] . Analysis of spFRET in mononucleosomes revealed two structurally different subpopulations of nucleosomes: a major subpopulation with high FRET values (high-FRET), and a minor subpopulation with low FRET values (low-FRET) ( Fig. 1 B) . Formation of nucleosome-PARP-1 complexes is characterized by: a) the narrowing of the high-FRET peak; b) appearance of a new intermediate-FRET peak; c) disappearance of the low-FRET peak (Fig 1 C) . After adding PARP-1 substrate NAD+ to the nucleosome-PARP-1 complexes a recovery of the original nucleosome structure occurs indicating dissociation of the complex during ADP-ribosylation (Fig 1 C) . Our study revealed that 7-MG does not affect the structure of free nucleosomes, but enhances PARP-1 binding to
